Physician profile
Sony Thomas
NPI 1376958322
$2,531.66
in general payments reported to CMS, 2019-2025
13 companies · $716 in 2025
The $716 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $29.01 · 2021: $178 · 2022: $336 · 2023: $554 · 2024: $407 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,675.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $650.90 | 2019-2025 | Myday Contact Lens, Onefit Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $457.84 | 2021-2025 | Precision7, Total30, Precision 7 |
| Bausch & Lomb Americas INC. | $330.57 | 2023-2024 | Infuse, Xiidra, Miebo |
| Tarsus Pharmaceuticals, INC. | $313.38 | 2024-2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $152.44 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Oyster Point Pharma, INC. | $141.52 | 2022-2024 | Ryzumvi, Tyrvaya |
| Glaukos Corporation | $117.18 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.83 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $91.21 | 2022-2024 | Acuvue |
| Allergan, INC. | $72.29 | 2019 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Oasis Medical, INC. | $12.93 | 2019 | |
| Optos, INC. | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sony Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.